Given the established oncogenic function of PIM kinases in CLL cells,9, 22 we first assessed the expression of PIM1, PIM2 and PIM3 on both transcript and protein levels in a group of 88 newly diagnosed CLL patients, and the obtained results were correlated with the clinical data. Here, PIM2 is linked to B-cell chronic lymphocytic leukemia.